Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
The government of India unveiled the "Manthan" platform to drive collaboration between the industry and research institutes to implement technology-based social impact innovations and solutions in the country.
EXAMIANS